IGM Biosciences Stock Quote IGMS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

12.14

Bid

12.06

Ask

12.22

Volume

199,422

11.17 Day's Range 12.64

3.81 52 Week Range 17.70

Market Cap

716.546M

Previous Close

11.60

Open

11.60

Last Trade

12.06

Last Trade Time

12:54:55

Financial Volume

$ 2,411,629

VWAP

12.0931

Average Volume (3m)

359,263

Shares Outstanding

59,023,575

Dividend Yield

PE Ratio

-2.94

Earnings Per Share (EPS)

-4.17

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

1970

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was $11.60. Over the last year, IGM Biosciences shares have traded in a share price range of $ 3.81 to $ 17.70.

IGM Biosciences currently has 59,023,575 shares outstanding. The market capitalization of IGM Biosciences is $684.67 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -2.94.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.4542	3.88676855671	11.6858	12.75	9.84	555461	11.08787303	CS
4	5.36	79.0560471976	6.78	12.75	6.1721	399164	9.41664524	CS
12	2.51	26.0643821391	9.63	12.75	6.1721	359263	9.31630542	CS
26	0.02	0.16501650165	12.12	17.7	6.1721	316548	10.25373038	CS
52	1.96	19.2534381139	10.18	17.7	3.81	308641	8.6783393	CS
156	-73.78	-85.8705772812	85.92	87.22	3.81	345239	20.23833668	CS
260	-6.17	-33.6974330967	18.31	133	3.81	276434	31.00936616	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUZENuZee Inc	$ 3.19 (209.71%)	96.75M
DRMADermata Therapeutics Inc	$ 2.75 (111.54%)	57.18M
PIRSPieris Pharmaceuticals Inc	$ 14.49 (81.58%)	5.19M
QXOQXO Inc	$ 128.25 (61.73%)	152.34k
BBLGBone Biologics Corporation	$ 1.93 (54.40%)	37.47M
NXTTNext Technology Holding Inc	$ 2.79 (-52.06%)	754.99k
NUWENewellis Inc	$ 2.48 (-40.24%)	877.64k
VWEVintage Wine Estates Inc	$ 0.069746 (-37.67%)	21.91M
CJETChijet Motor Company Inc	$ 3.29 (-35.24%)	327.41k
CONNConns Inc	$ 0.3332 (-34.28%)	3.23M
SLNASelina Hospitality PLC	$ 0.034 (30.77%)	944.16M
SGMOSangamo Therapeutics Inc	$ 0.566 (41.04%)	218.57M
NVDANVIDIA Corporation	$ 116.415 (-5.04%)	149.56M
SQQQProShares UltraPro Short QQQ	$ 8.925 (9.11%)	117.79M
TSLATesla Inc	$ 221.0425 (-10.28%)	114.02M